Platelet antiaggregation after an acute coronary syndrome: what about the elderly?
- PMID: 36367685
- DOI: 10.1093/eurheartj/ehac405
Platelet antiaggregation after an acute coronary syndrome: what about the elderly?
Conflict of interest statement
Conflict of interest: K.H. received lecture fees from AstraZeneca, Daiichi Synkyo and Sanofi Aventis; and I was co-author of several studies referenced in this paper: GLOBAL LEADERS (7), TWILIGHT (8), TROPICAL ACS (10).
Comment on
-
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.Eur Heart J. 2022 Dec 21;43(48):5037-5044. doi: 10.1093/eurheartj/ehac402. Eur Heart J. 2022. PMID: 36367709
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
